tallózása szerző szerint "Szilágyi, Ágnes"

1-20 / 28

Következő oldal

A haemolyticus uraemiás szindróma diagnosztikájának és terápiájának aktuális kérdései : 2. rész: A betegek hosszú távú kezelésének és gondozásának szempontjai.

Prohászka, Zoltán; Szilágyi, Ágnes; Réti, Marienn Györgyi; Szabó, Attila; Reusz, György (2011)
Analysis of linear antibody epitopes on factor H and CFHR1 using sera of patients with autoimmune atypical hemolytic uremic syndrome

Trojnár, Eszter; Józsi, Mihály; Uray, Katalin; Csuka, Dorottya; Szilágyi, Ágnes; Milosevic D; Stojanovic VD; Spasojevic ́ B; Rusai K; Müller T; Arbeiter K; Kelen, Kata; Szabó, Attila J; Reusz, György S; Hyvärinen S; Jokiranta TS; Prohászka, Zoltán (2017)
Analysis of the 8.1 ancestral MHC haplotype in severe, pneumonia-related sepsis

Aladzsity, István; Madách, Krisztina; Szilágyi, Ágnes; Gál, János; Pénzes, István; Prohászka, Zoltán; Füst, György (2011)
Association between estrogen receptor alpha gene polymorphisms and early restenosis after eversion carotid endarterectomy and carotid stenting

Hirschberg K; Gombos, Tímea; Dósa, Edit; Somorjai A; Szilágyi, Ágnes; Szabó, Gábor Balázs; Füst, György; Entz, László (2009)

Objective: Our aim was to identify the role of PvuII and XbaI polymorphisms of the ESR1 (estrogen receptor alpha) gene in the occurrence of early restenosis after carotid endarterectomy and carotid artery stenting. Methods: ...
Both Positive and Negative Selection Pressures Contribute to the Polymorphism Pattern of the Duplicated Human CYP21A2 Gene.

Szabo JA; Szilágyi, Ágnes; Doleschall, Zoltán; Patócs, Attila Balázs; Farkas, Henriette; Prohászka, Zoltán; Rácz, Károly; Füst, György; Doleschall, Márton (2013)

The human steroid 21-hydroxylase gene (CYP21A2) participates in cortisol and aldosterone biosynthesis, and resides together with its paralogous (duplicated) pseudogene in a multiallelic copy number variation (CNV), called ...
C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy

Garam, Nóra; Prohászka, Zoltán; Szilágyi, Ágnes; Christof, Aigner; Alice, Schmidt; Martina, Gaggl; Gere, Sunder-Plassmann; Bajcsi, Dóra; Jürgen, Brunner; Alexandra, Dumfarth; Daniel, Cejka; Stefan, Flaschberger; Hana, Flögelova; Ágnes, Haris; Ágnes, Hartmann; Andreas, Heilos; Thomas, Mueller; Rusai, Krisztina; Klaus, Arbeiter; Johannes, Hofer; Dániel, Jakab; Mária, Sinkó; Erika, Szigeti; Csaba, Bereczki; Viktor, Janko; Kelen, Kata; Reusz, György; Szabó, Attila; Nóra, Klenk; Krisztina, Kóbor; Nika, Kojc; Maarten, Knechtelsdorfer; Mario, Laganovic; Adrian, Catalin Lungu; Anamarija, Meglic; Rina, Rus; Tanja, Kersnik-Levart; Ernesta, Macioniene; Marius, Miglinas; Anna, Pawłowska; Tomasz, Stompór; Ludmila, Podracka; Michael, Rudnicki; Gert, Mayer; Romana, Rysava; Jana, Reiterova; Marijan, Saraga; Tomáš, Seeman; Jakub, Zieg; Eva, Sládková; Szabó, Tamás; Andrei, Capitanescu; Simona, Stancu; Miroslav, Tisljar; Kresimir, Galesic; Tislér, András; Inga, Vainumäe; Martin, Windpessl; Tomas, Zaoral; Galia, Zlatanova; Csuka, Dorottya (2019)
Compared efficacy of preservation solutions on the outcome of liver transplantation: Meta-analysis

Szilágyi, Ágnes; Mátrai, Péter; Hegyi, Péter; Tuboly, Eszter; Pecz D; Garami, András; Szekeres-Solymár, Margit; Rittmann-né Pétervári, Erika; Balaskó, Márta; Veres, Gábor; Czopf, László; Wobbe B; Szabo D; Wagner J; Hartmann, Petra (2018)

AIM: To compare the effects of the four most commonly used preservation solutions on the outcome of liver transplantations. METHODS: A systematic literature search was performed using MEDLINE, Scopus, EMBASE and the Cochrane ...
Concentration and Subclass Distribution of Anti-ADAMTS13 IgG Autoantibodies in Different Stages of Acquired Idiopathic Thrombotic Thrombocytopenic Purpura

Sinkovits, György; Szilágyi, Ágnes; Farkas, Péter; Inotais D; Szilvasi A; Tordai A; Razso K; Reti M; Prohászka, Zoltán (2018)

Background: The acquired form of idiopathic thrombotic thrombocytopenic purpura (TTP) is an autoimmune disease, in which the underlying deficiency of the ADAMTS13 protease is caused by autoantibodies, predominantly of the ...
Diagnosis and classification of hemolytic uremic syndrome

Reusz, György; Szabó, Attila; Reti M; Gyorke Z; Szilágyi, Ágnes; Farkas, Péter; Prohászka, Zoltán (2011)

BACKGROUND: Hemolytic uremic syndrome (HUS) is a rare disease with various etiologies, making the identification of the specific forms and appropriate treatment difficult. Therefore, clinical and laboratory data from ...
Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients

Frida C Mohlin; Sara C. Nilsson; Tanja Kersnik Levart; Ema Golubovic; Krisztina Rusai; Thomas Müller-Sacherer; Klaus Arbeiter; Pállinger, Éva; Szarvas, Nóra; Csuka, Dorottya; Szilágyi, Ágnes; Bruno O. Villoutreix; Prohászka, Zoltán; Anna M. Blom (2015)
Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome

Szarvas Nóra; Szilágyi, Ágnes; Csuka, Dorottya; Takács Beáta; Rusai, Krisztina; Müller Thomas; Arbeiter Klaus; Réti Marienn; Haris Ágnes; Wágner, László József; Török, Szilárd; Kelen, Kata; Szabó, Attila; Reusz, György; Morgan B Paul; Prohászka, Zoltán (2016)

Abstract Atypical hemolytic uremic syndrome (aHUS) is a rare disorder caused by dysregulation of the complement alternative pathway, and associated with mutations in genes of complement components and regulators. In the ...
Genotyping and haplotyping of the dopamine D4 receptor gene by capillary electrophoresis

Szantai, Eszter; Szilágyi, Ágnes; Guttman, András; Sasvári-Székely, Mária; Rónai, Zsolt (2004)

In this paper we report on simultaneous genotyping of adjacent polymorphisms (referred to as haplotyping) by combining double-tube allele-specific polymerase chain reaction, restriction fragment length polymorphism and ...
Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome.

Nozal P,; Bernabeu-Herrero ME,; Uzonyi, Barbara; Szilágyi, Ágnes; Hyvarinen S,; Prohászka, Zoltán; Jokiranta TS; Sanchez-Corral P; Lopez-Trascasa M; Józsi, Mihály (2016)

Factor H (FH) autoantibodies are present in 6-10% of atypical hemolytic uremic syndrome (aHUS) patients, most of whom have homozygous deficiency of the FH-related protein FHR-1. Although the pathogenic role of the ...
High rate of in-stent restenosis after coronary intervention in carriers of the mutant mannose-binding lectin allele

Bagyura, Zsolt; Kiss L; Berta, Balázs; Szilágyi, Ágnes; Hirschberg K; Széplaki, Gábor; Lux, Árpád; Szelid, Zsolt László; Soós, Pál; Merkely, Béla Péter (2017)

BACKGROUND: In-stent restenosis occurs in 10-30% of patients following bare metal stent (BMS) implantation and has various risk factors. Mannose-binding lectin (MBL) is known to have effect on the progression of atherosclerosis. ...
Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations.

Bors, András; Csuka, Dorottya; Varga, Lilian; Farkas, Henriette; Tordai, Attila; Füst, György; Szilágyi, Ágnes (2013)
Multivariate Analysis of Dopaminergic Gene Variants as Risk Factors of Heroin Dependence

Vereczkei, Andrea; Demetrovics, Zsolt; Székely, Anna; Sárközy, Péter; Antal, Péter; Szilágyi, Ágnes; Sasvári-Székely, Mária; Barta, Csaba (2013)
Novel duplication in the F12 gene in a patient with recurrent angioedema.

Szarvas, Nóra; Barabas E; Varnai K; Halasz A; Varga, Lilian; Prohászka, Zoltán; Farkas, Henriette; Szilágyi, Ágnes (2013)

Edema formation is mediated by histamine or bradykinin release and may have several hereditary and acquired causes. In hereditary forms of bradykinin-mediated angioedemas, mutations in the genes encoding C1-inhibitor ...
Polymorphisms of TNF-alpha and LT-alpha genes in multiple myeloma

Kádár, Katalin Eszter; Kovács, M; Karádi, István; Melegh, Béla; Pocsai, Z; Mikala, Gábor; Tordai, Attila; Szilágyi, Ágnes; Ádány, Róza; Füst, György; Várkonyi, Judit (2008)

Allelic distribution of -308 G>A (TNF 1/2) polymorphism of the TNF-alpha, and the +252 A>G promoter polymorphism of the LT-alpha gene, the 1267 A>G polymorphism of the HSP70-2 gene as well as the -429 T>C promoter ...
Primer immundeficiencia - komplementdefektus. Laborvizsgálatok bemutatása egy betegünk kapcsán

Szilágyi, Ágnes; Varga, Lilian; Prohászka, Zoltán; Dérfalvi, Beáta (2014)
Role of complement in the pathogenesis of thrombotic microangiopathies

Trojnár, Eszter; Szilágyi, Ágnes; Mikes B,; Csuka, Dorottya; Sinkovits, György; Prohászka, Zoltán (2018)

1-20 / 28

Következő oldal

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Szilágyi, Ágnes"

DSpace/Manakin Repository

tallózása szerző szerint "Szilágyi, Ágnes"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem